Legacy CEQ-compiled dataset (pre-authoritative baseline)
Compiled reference Food and Drug Administration's Categorical Exclusions (opens in new tab)Categorical Exclusion
§25.33 Animal drugs.
Exclusion Text
(d) Action on an NADA, abbreviated application, request for determination of eligibility for indexing, a supplement to such applications, or a modification of an index listing, for:
(1) Drugs intended for use in nonfood animals;
(2) Anesthetics, both local and general, that are individually administered;
(3) Nonsystemic topical and ophthalmic animal drugs;
(4) Drugs for minor species, including wildlife and endangered species, when the drug has been previously approved for use in another or the same species where similar animal management practices are used; and
(5) Drugs intended for use under prescription or veterinarian's order for therapeutic use in terrestrial species.
Provenance
- Agency: Legacy CEQ-compiled dataset (pre-authoritative baseline) (LEGACY)
- Source provenance: Compiled reference
- Source type: legacy seed
- Identifier:
FDA---4-44 - Fetched at: 1970-01-01T00:00:00+00:00 (not an agency verification date)
Source legal reference
CEQ-compiled compendium of Federal categorical exclusions (historical, non-authoritative baseline)
Disclaimer
This CE Explorer tool is not an authoritative source and creates no rights or obligations. Review the relevant agency's NEPA procedures before applying a categorical exclusion.
When using the CE Explorer Tool, Federal agencies and stakeholders should review the relevant agency's NEPA procedures for information about how to apply the CE, including any limitations or potential extraordinary circumstances, and to ensure that a CE is current and applicable to a given proposed action. To adopt and use another agency's categorical exclusion, an agency must follow the steps described in section 109 of NEPA, 42 U.S.C. 4336c.
